Form 3GTBPCIK 0000109657

GT Biopharma, Inc.

Name: SEC EDGAR filing 0001641172-25-021546
Creator: GT Biopharma, Inc.
License: https://www.usa.gov/government-works

Initial insider ownership (Form 3) filed July 30, 2025.

Initial statement of beneficial ownership filed by a company's officers, directors, and 10%+ owners when they first become an insider.

Read the filing on SEC.gov All documents in this filing

Filing facts

Accession number: 0001641172-25-021546
Filer: GT Biopharma, Inc.
Ticker: GTBP
CIK: 0000109657
Form type: Form 3
Form description: Initial insider ownership
Filed at: July 30, 2025
Period of report: June 10, 2025
Industry: SIC 2834Pharmaceutical Preparations
Filing size: 3.2 KB
Last verified: August 26, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from GT Biopharma, Inc.

See all 45 filings from GT Biopharma, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/109657/000164117225021546/0001641172-25-021546-index.htm ↗

Filer's full EDGAR submission history

EDGAR · GT Biopharma, Inc. (0000109657) ↗

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.